KKR Genetic Disorder L.P.

Insider profile

Performance

Overall performance
2.1

Performance over holding periods
2.1
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 33% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
KKR Genetic Disorder L.P.'s trades of BridgeBio Pharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
156.49
Quantity 69,668 -26.9%
Value US$1,382,254
Transaction date
Proposed sale
Price
91.91
Quantity 74,336
Value US$4,928,259
Transaction date
Proposed sale
Price
34.97
Quantity 6,000,000
Value US$209,820,000
Transaction date
Sale
Price
25.75
Quantity 5,800,000 -18.7%
Value US$149,350,000
Transaction date
Proposed sale
Price
26.95
Quantity 5,800,000
Value US$156,310,000
Transaction date
Sale
Price
60.47
Quantity 3,450,000 -10.0%
Value US$208,617,360
Transaction date
Sale
Price
33.39
Quantity 2,389,690 -6.5%
Value US$79,791,749
Transaction date
Purchase
Price
17.00
Quantity 2,647,100 +7.7%
Value US$45,000,700
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-05-14 2025-05-12 S Sale
69,668 -26.9%
156.49
US$1,382,254
69,668 -26.9% 156.49 US$1,382,254
2025-05-12 2025-05-12 PrS Proposed sale
74,336
91.91
US$4,928,259
74,336 91.91 US$4,928,259
2025-03-07 2025-03-05 S Sale
32,928 -44.7%
359.47
US$2,374,348
32,928 -44.7% 359.47 US$2,374,348
2025-03-05 2025-03-05 PrS Proposed sale
6,000,000
34.97
US$209,820,000
6,000,000 34.97 US$209,820,000
2024-09-17 2024-09-13 S Sale
5,800,000 -18.7%
25.75
US$149,350,000
5,800,000 -18.7% 25.75 US$149,350,000
2024-09-13 2024-09-13 PrS Proposed sale
5,800,000
26.95
US$156,310,000
5,800,000 26.95 US$156,310,000
2021-02-17 2021-02-17 S Sale
3,450,000 -10.0%
60.47
US$208,617,360
3,450,000 -10.0% 60.47 US$208,617,360
2020-06-01 2020-05-28 S Sale
2,389,690 -6.5%
33.39
US$79,791,749
2,389,690 -6.5% 33.39 US$79,791,749
2019-07-03 2019-07-01 B Purchase
2,647,100 +7.7%
17.00
US$45,000,700
2,647,100 +7.7% 17.00 US$45,000,700